In a preclinical human colon cancer cell growth and metastasis model in nude mice, orally active CXCR2/CXCR1 antagonists partially decreased liver metastasis by reducing tumor neovascularization through CXCR2 signaling [43]. This evidence concerns the gene CXCR1 and colonic neoplasm.